References
- Garrison LP Jr, Neumann PJ, Erickson P, et al. Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report. Value Health. 2007 Sep;10:326–335. doi: 10.1111/j.1524-4733.2007.00186.x
- Concato J, Corrigan-Curay J. Real-world evidence – where are we Now? N Engl J Med. 2022 May;386:1680–1682. doi: 10.1056/NEJMp2200089
- Rawlins M. De Testimonio: on the evidence for decisions about the use of therapeutic interventions. Clin Med. 2008 Dec;8(6):579–588. doi: 10.7861/clinmedicine.8-6-579
- Heckman JJ, Pinto R Causality and econometrics [internet]. National Bureau of Economic Research. 2022 Feb. p. 80. [cited 2023 Sep 6]. https://www.nber.org/system/files/working_papers/w29787/w29787.pdf
- Snyder CR, Ford C. Coping with negative life events: clinical and social psychological perspectives. (NY): Springer Science; 2013. p. 12.
- Li I, Pan J, Goldwasser J, et al. Neural natural language processing for unstructured data in electronic health records: a review. Comput Sci Rev. Nov 2022;46:100511. doi: 10.1016/j.cosrev.2022.100511
- U.S. Department of Health and Human Services Food and Drug Administration. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for Drug and biological products, guidance for industry [internet]. Rockville (MD): Food and Drug Administration; p. 12. 2021 Dec [cited 2022 Sep 26]. Available from: https://www.fda.gov/media/154714/download
- IBM Cloud Education. What is machine learning? Armonk (NY); IBM; 2020 Jul [cited 2022 Sep 26]. Available from: https://www.ibm.com/cloud/learn/machine-learning
- U.S. Department of Health and Human Services Food and Drug Administration. Using artificial intelligence & machine learning in the development of drug & biologic products: discussion paper and request for feedback [internet]. Food and Drug Administration; 2023 May p. 33. [cited 2023 Sep 6] Available from: https://www.fda.gov/media/167973/download
- Chase H, Mitrani L, Lu G, et al. Early recognition of multiple sclerosis using natural language processing of the electronic health record. BMC Med Inform Decis Mak. 2017 Feb;17(1):24. doi: 10.1186/s12911-017-0418-4
- Crown WH. Real-world evidence, causal inference, and machine learning. Value Health. 2019 May;22(5):587–592. doi: 10.1016/j.jval.2019.03.001
- Hernán MA, Hsu J, Healy B. Data science is science’s second chance to get causal inference right: a classification of data science tasks. Chance. 2019 May;32:42–49. doi: 10.1080/09332480.2019.1579578
- Padula W, Kreif N, Vanness D, et al. Machine learning methods in health economics and outcomes research—the PALISADE checklist: a good practices report of an ISPOR task force. Value Health. 2022 Jul;25(7):1063–1080. doi: 10.1016/j.jval.2022.03.022